Dan Durkin, technical team lead on the Clinical Knowledgebase (CKB), gives a first hand explanation of this powerful tool (available to anyone) that allows clinicians and researchers to better interpret complex cancer genomic profiles.
JAX Professor Robert Burgess, Ph.D., investigates the genetic and molecular mechanisms underlying peripheral nerve degeneration in CMT, and his new findings may advance cutting edge genetic treatments for this and other rare disease.
Donna is a 60-year-old Black woman with a personal history of breast cancer, diagnosed at age 49. Her oncologist recommended she consider genetic testing at the time. However, when she met with a genetic counselor she was not able to access testing.